Testing the Addition of an Anti-cancer Drug, Lenalidomide, to the Usual Combination Chemotherapy Treatment ("EPOCH") for Adult T-Cell Leukemia-Lymphoma (ATLL)

NCT04301076 · clinicaltrials.gov ↗

PHASE1

Phase

SUSPENDED

Status

30

Enrollment

NIH

Sponsor class

Stopped Other - Pending amendment.

Conditions

Acute Adult T-Cell Leukemia/Lymphoma
Adult T-Cell Leukemia/Lymphoma
Chronic Adult T-Cell Leukemia/Lymphoma
HTLV-1 Infection

Interventions

PROCEDURE: Biospecimen Collection
PROCEDURE: Bone Marrow Biopsy
PROCEDURE: Computed Tomography
DRUG: Cyclophosphamide
DRUG: Doxorubicin Hydrochloride
DRUG: Etoposide
DRUG: Lenalidomide
PROCEDURE: Positron Emission Tomography
DRUG: Prednisone
DRUG: Vincristine Sulfate

Sponsor

National Cancer Institute (NCI)